SPONSOR
Incyte Corporation
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1
Conditions studied: Moderate to Severe AsthmaOvarian CancerHidradenitis SuppurativaHealthy ParticipantsPregnancy RelatedAtopic Dermatitis
Incyte Corporation is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Moderate to Severe Asthma, Ovarian Cancer, Hidradenitis Suppurativa, Healthy Participants.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Incyte Corporation
How many clinical trials has Incyte Corporation sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Incyte Corporation, of which 5 are actively recruiting participants. These trials cover conditions including Moderate to Severe Asthma, Ovarian Cancer, Hidradenitis Suppurativa. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Incyte Corporation research focus on?
Incyte Corporation clinical trials span Moderate to Severe Asthma, Ovarian Cancer, Hidradenitis Suppurativa, Healthy Participants, Pregnancy Related, and additional conditions. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Incyte Corporation clinical trial?
To participate in a Incyte Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Incyte Corporation trials with current recruitment status updated daily.
Clinical Trials by Incyte Corporation
NCT05851443 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Moderate to Severe Asthma
NCT07023627 Phase 2
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Ovarian Cancer
NCT07049575 Phase 1
Recruiting
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
NCT07588139 Phase 1
Recruiting
A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants
Healthy Participants
NCT06259669
Recruiting
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Pregnancy Related
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology